In addition, we also found that the administration of SS-1 prior to induction could reduce the concentrations of TNF-α, IL-1β, and IL-6 in BALF due to LPS-induced ALI, as well as increased cytokine synthesis inhibitory factor IL-10 concentration, thus alleviating the lung tissue injury. The gene discussed is IL1B; the disease is acute respiratory distress syndrome.